CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Net Cash Flow Growth by Quarter and Year

Merck And Co Inc 's Net Cash Flow results by quarter and year




MRK Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 764.00 1,967.00 -
III Quarter September - -3,746.00 - -
II Quarter June - 3,687.00 -1,307.00 -
I Quarter March -1,142.00 -2,474.00 - -
FY   -1,142.00 -1,769.00 660.00 -



MRK Net Cash Flow first quarter 2021 Y/Y Growth Comment
Merck and Co Inc in the first quarter recorded net cash outflow of $ -1,142.00 millions.

According to the results reported in the first quarter, Merck And Co Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Merck And Co Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter.




MRK Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - -61.16 % - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Merck And Co Inc 's first quarter 2021 Net Cash Flow $ -1,142.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2020 Net Cash Flow $ -2,474.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Net Cash Flow Growth >>


MRK Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Merck And Co Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's I. Quarter Q/Q Net Cash Flow Comment
I. Quarter 2021 results of -1,142.00 millions by Merck and Co Inc look even worse considering the 764.00 millions net cash outflow in the forth quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's I. Quarter Q/Q Net Cash Flow Comment
I. Quarter 2021 accomplishment of -1,142.00 millions by Merck and Co Inc appear even less good considering the 764.00 millions a quarter before.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Merck And Co Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ -437.00 $ -1,769.00 $ -566.00 $ 4,487.00 $ -507.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Merck and Co Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Merck and Co Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
MRK's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for MRK's Competitors
Net Cash Flow Growth for Merck And Co Inc 's Suppliers
Net Cash Flow Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.89%$ -0.893 millions
Catalyst Biosciences Inc -4.20%$ -4.202 millions
Igm Biosciences Inc -7.14%$ -7.136 millions
Alector Inc -14.79%$ -14.790 millions
Myriad Genetics Inc -19.85%$ -19.849 millions
Inogen Inc -22.01%$ -22.015 millions
Verrica Pharmaceuticals Inc -26.15%$ -26.147 millions
Aclaris Therapeutics Inc -26.87%$ -26.868 millions
Biodelivery Sciences International Inc -27.85%$ -27.851 millions
Align Technology inc -28.90%$ -28.896 millions
United Therapeutics Corporation-31.58%$ -31.579 millions
Vertex Pharmaceuticals Inc-32.67%$ -32.667 millions
Syros Pharmaceuticals inc -35.91%$ -35.911 millions
Agenus Inc-35.92%$ -35.917 millions
Iradimed Corp-36.52%$ -36.522 millions
Assertio Holdings inc -36.98%$ -36.982 millions
Zymeworks Inc -37.89%$ -37.885 millions
Deciphera Pharmaceuticals Inc -39.86%$ -39.862 millions
Chiasma Inc -39.98%$ -39.980 millions
Nevro Corp -40.87%$ -40.865 millions
Xencor Inc-42.88%$ -42.880 millions
Vanda Pharmaceuticals Inc -44.17%$ -44.167 millions
Myomo Inc -44.61%$ -44.607 millions
Passage Bio Inc -44.93%$ -44.931 millions
Innoviva inc -50.73%$ -50.730 millions
Biomarin Pharmaceutical Inc-53.67%$ -53.670 millions
Transmedics Group Inc -53.81%$ -53.810 millions
Kala Pharmaceuticals inc -54.32%$ -54.323 millions
Puma Biotechnology Inc -54.64%$ -54.635 millions
Bio techne Corp-55.12%$ -55.122 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MPB's Profile

Stock Price

MPB's Financials

Business Description

Fundamentals

Charts & Quotes

MPB's News

Suppliers

MPB's Competitors

Customers & Markets

Economic Indicators

MPB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071